Menu Close

Summary*

SWORD Health, founded in 2015 and headquartered in Draper, Utah, is a leading digital health company specializing in physical therapy and pain management solutions. The company leverages artificial intelligence to provide personalized care for musculoskeletal (MSK) conditions, serving employers, health plans, and individuals.

Since its inception, SWORD Health has demonstrated significant growth and innovation in the healthcare technology sector. The company has successfully raised substantial funding, with its latest Series E round in June 2024 bringing in $30 million at a valuation of $3 billion. This funding history, which includes investments from prominent firms like Khosla Ventures and General Catalyst, underscores investor confidence in SWORD Health's business model and market potential.

While there is currently no official information available regarding SWORD Health's IPO prospects, the company's strong financial backing and innovative approach to digital health solutions position it as a notable player in the healthcare technology industry. Factors that could potentially influence any future IPO considerations include the company's continued growth, market conditions, and the overall performance of the digital health sector.

It's important to note that without official announcements or confirmed reports, any discussion of SWORD Health's IPO plans remains speculative. Potential investors interested in SWORD Health should continue to monitor official company communications and verified financial news sources for the most up-to-date and accurate information regarding any possible future public offering.

How to invest in SWORD Health

While SWORD Health's IPO prospects remain uncertain, investors interested in the digital health and physical therapy space don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in the healthcare technology sector. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of innovative companies like SWORD Health before they go public.

*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.